GSK 6-K
GSK plc (GSK)
6-K
2025-06-24
For: 2025-06-24
View Original
Added on
April 10, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2025
Commission File Number 001-15170
GSK plc
(Translation of registrant's name into English)
79 New Oxford Street, London, WC1A 1DG
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc (the 'Company')
Transaction notification
| 1. | Details of PDMR/person closely associated with them<br>('PCA') | ||||
|---|---|---|---|---|---|
| a) | Name | Sally<br>Jackson | |||
| b) | Position/status | SVP,<br>Global Communications & CEO Office | |||
| c) | Initial<br>notification/amendment | Initial notification | |||
| 2. | Details of the issuer, emission allowance market participant,<br>auction platform, auctioneer or auction monitor | ||||
| a) | Name | GSK plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each<br>type of instrument; (ii) each type of transaction; (iii) each date;<br>and (iv) each place where transaction(s) has been<br>conducted | ||||
| a) | Description<br>of the financial instrument | Ordinary shares of 31 ¼ pence each ('Ordinary<br>Shares')<br><br><br>ISIN: GB00BN7SWP63 | |||
| b) | Nature<br>of the transaction | Gift of<br>ordinary shares to family member for nil consideration | |||
| c) | Price(s)<br>and volume(s) | Price(s) | Volume(s) | ||
| £0.00 | 1,400 | ||||
| d) | Aggregated<br>information | N/A (single transaction) | |||
| Aggregated<br>volume<br><br>Price | |||||
| e) | Date<br>of the transaction | 2025-06-19 | |||
| f) | Place<br>of the transaction | London Stock Exchange (XLON) | |||
| 1. | Details of PDMR/person closely associated with them<br>('PCA') | ||||
| --- | --- | --- | --- | --- | --- |
| a) | Name | Sally Jackson | |||
| b) | Position/status | SVP, Global Communications & CEO Office | |||
| c) | Initial<br>notification/amendment | Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant,<br>auction platform, auctioneer or auction monitor | ||||
| a) | Name | GSK plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each<br>type of instrument; (ii) each type of transaction; (iii) each date;<br>and (iv) each place where transaction(s) has been<br>conducted | ||||
| a) | Description of the financial instrument | Ordinary Shares of 31 ¼ pence each ('Ordinary<br>Shares')<br><br><br>ISIN: GB00BN7SWP63 | |||
| b) | Nature of<br>the transaction | The sale of 1,395 Ordinary Shares to facilitate a transfer into an<br>ISA | |||
| c) | Price(s)<br>and volume(s) | Price(s) | Volume(s) | ||
| £14.3524 | 1,395 | ||||
| d) | Aggregated information | N/A (single transaction) | |||
| Aggregated volume<br><br>Price | |||||
| e) | Date of the transaction | 2025-06-19 | |||
| f) | Place<br>of the transaction | London Stock Exchange (XLON) | |||
| 1. | Details of PDMR/person closely associated with them<br>('PCA') | ||||
| --- | --- | --- | --- | --- | --- |
| a) | Name | Sally Jackson | |||
| b) | Position/status | SVP, Global Communications & CEO Office | |||
| c) | Initial<br>notification/amendment | Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant,<br>auction platform, auctioneer or auction monitor | ||||
| a) | Name | GSK plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each<br>type of instrument; (ii) each type of transaction; (iii) each date;<br>and (iv) each place where transaction(s) has been<br>conducted | ||||
| a) | Description of the financial instrument | Ordinary Shares of 31 ¼ pence each ('Ordinary<br>Shares')<br><br><br>ISIN: GB00BN7SWP63 | |||
| b) | Nature of<br>the transaction | The purchase of 1,387 Ordinary Shares into an ISA | |||
| c) | Price(s)<br>and volume(s) | Price(s) | Volume(s) | ||
| £14.3378 | 1,387 | ||||
| d) | Aggregated information | N/A (single transaction) | |||
| Aggregated volume<br><br>Price | |||||
| e) | Date of the transaction | 2025-06-19 | |||
| f) | Place<br>of the transaction | London Stock Exchange (XLON) | |||
| 1. | Details of PDMR/person closely associated with them<br>('PCA') | ||||
| --- | --- | --- | --- | --- | --- |
| a) | Name | Dylan Jackson | |||
| b) | Position/status | PCA of Sally Jackson (SVP, Global Communications & CEO<br>Office) | |||
| c) | Initial<br>notification/amendment | Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant,<br>auction platform, auctioneer or auction monitor | ||||
| a) | Name | GSK plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each<br>type of instrument; (ii) each type of transaction; (iii) each date;<br>and (iv) each place where transaction(s) has been<br>conducted | ||||
| a) | Description of the financial instrument | Ordinary Shares of 31 ¼ pence each ('Ordinary<br>Shares')<br><br><br>ISIN: GB00BN7SWP63 | |||
| b) | Nature of<br>the transaction | The sale of 1,395 Ordinary Shares to facilitate a transfer into an<br>ISA | |||
| c) | Price(s)<br>and volume(s) | Price(s) | Volume(s) | ||
| £14.3524 | 1,395 | ||||
| d) | Aggregated information | N/A (single transaction) | |||
| Aggregated volume<br><br>Price | |||||
| e) | Date of the transaction | 2025-06-19 | |||
| f) | Place<br>of the transaction | London Stock Exchange (XLON) | |||
| 1. | Details of PDMR/person closely associated with them<br>('PCA') | ||||
| --- | --- | --- | --- | --- | --- |
| a) | Name | Dylan Jackson | |||
| b) | Position/status | PCA of Sally Jackson (SVP, Global Communications & CEO<br>Office) | |||
| c) | Initial<br>notification/amendment | Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant,<br>auction platform, auctioneer or auction monitor | ||||
| a) | Name | GSK plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each<br>type of instrument; (ii) each type of transaction; (iii) each date;<br>and (iv) each place where transaction(s) has been<br>conducted | ||||
| a) | Description of the financial instrument | Ordinary Shares of 31 ¼ pence each ('Ordinary<br>Shares')<br><br><br>ISIN: GB00BN7SWP63 | |||
| b) | Nature of<br>the transaction | The purchase of 1,385 Ordinary Shares into an ISA | |||
| c) | Price(s)<br>and volume(s) | Price(s) | Volume(s) | ||
| £14.3537 | 1,385 | ||||
| d) | Aggregated information | N/A (single transaction) | |||
| Aggregated volume<br><br>Price | |||||
| e) | Date of the transaction | 2025-06-19 | |||
| f) | Place<br>of the transaction | London Stock Exchange (XLON) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
| GSK plc | |
|---|---|
| (Registrant) | |
| Date:<br>June 24, 2025 | |
| By:/s/ VICTORIA<br>WHYTE<br><br>-------------------------- | |
| Victoria Whyte | |
| Authorised<br>Signatory for and on | |
| behalf<br>of GSK plc |